Previously, we described the pathological increase in active (P-Y216)-GSK3β (also called active GSK3β) in skeletal muscle biopsies and primary myoblasts from patients with adult-onset DM1 and CDM1 [9,18]. Here, GSK3B is linked to myotonic dystrophy type 1.